GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 126 filers reported holding GENOMIC HEALTH INC in Q1 2017. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $905,000 | -18.0% | 27,798 | -20.6% | 0.36% | -0.8% |
| Q1 2017 | $1,103,000 | -30.6% | 35,026 | -35.2% | 0.36% | -15.8% |
| Q4 2016 | $1,589,000 | -15.6% | 54,058 | -16.9% | 0.42% | -5.8% |
| Q3 2016 | $1,882,000 | +17.6% | 65,086 | +5.4% | 0.45% | +53.4% |
| Q2 2016 | $1,600,000 | -24.1% | 61,773 | -27.4% | 0.29% | -3.3% |
| Q1 2016 | $2,108,000 | -3.7% | 85,095 | +36.8% | 0.30% | +28.8% |
| Q4 2015 | $2,190,000 | -43.7% | 62,222 | -66.1% | 0.24% | -37.1% |
| Q3 2015 | $3,888,000 | +36.5% | 183,744 | +79.3% | 0.38% | +34.9% |
| Q2 2015 | $2,848,000 | +349.9% | 102,481 | +394.4% | 0.28% | +348.4% |
| Q1 2015 | $633,000 | +6.4% | 20,730 | +11.5% | 0.06% | +8.8% |
| Q4 2014 | $595,000 | +0.5% | 18,598 | -11.0% | 0.06% | +11.8% |
| Q3 2014 | $592,000 | +71.6% | 20,905 | +66.1% | 0.05% | +88.9% |
| Q2 2014 | $345,000 | – | 12,586 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |